Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Clears Drug Chief of Conflict
Wall St Journal
Saturday, February 6, 2010 - 12:08pm
tags:
FDA
Drug stocks fall; Alkermes rallies on upgrade
MarketWatch
Saturday, February 6, 2010 - 12:06pm
tags:
Alkermes
Inhibitex Regains Compliance with NASDAQ Listing Requirements
Yahoo/BusinessWire
Saturday, February 6, 2010 - 12:05pm
tags:
Inhibitex
Talecris Biotherapeutics Receives Orphan Drug Designation for Aerosolized Alpha1-Proteinase Inhibitor to Treat Alpha1-Antitrypsin Deficiency
Yahoo/BusinessWire
Saturday, February 6, 2010 - 12:01pm
tags:
Talecris, orphan drugs, Alpha1-Proteinase Inhibitor, Alpha1-Antitrypsin Deficiency
FDA orders stronger label for Tysabri
bizjournals.com
Saturday, February 6, 2010 - 11:58am
tags:
Tysabri, Biogen Idec, PML, Elan
Optimer Pharma rises on fidaxomicin study data
Yahoo/AP
Saturday, February 6, 2010 - 11:53am
tags:
Optimer, C. difficile, fidaxomicin
Experts predict biotech doom with loss of gene patents
Fierce Biotech
Friday, February 5, 2010 - 10:50am
tags:
generics, Myriad, patents
Novo reps train for Victoza launch
Fierce Pharma
Friday, February 5, 2010 - 10:39am
tags:
Novo Nordisk, Victoza, sales reps, training
Wall Street Unleashes Fury at Pfizer's $1.5B Revenue Discrepancy
BNET Pharma
Friday, February 5, 2010 - 10:35am
tags:
Pfizer, earnings
Spending On Prescription Drugs Rose 5.2% In 2009
Pharmalot
Friday, February 5, 2010 - 10:33am
tags:
prescription data
AstraZeneca still waiting for the upside to MedImmune acquisition
Bizjournals.com
Friday, February 5, 2010 - 10:30am
tags:
MedImmune, AstraZeneca, M&A
FDA Derides ‘Conspiracy Theory’ Over Provenge Delay
Pharmalot
Friday, February 5, 2010 - 10:28am
tags:
Provenge, Dendreon, prostate cancer, FDA
Teva Pharma settles some Medicaid drug price suits
Yahoo/AP
Friday, February 5, 2010 - 10:27am
tags:
Medicaid, drug pricing, lawsuits, Teva Pharmaceuticals, settlements
CVS May Get Earnings ‘Windfall’ From Lipitor, Plavix Generics
Bloomberg
Friday, February 5, 2010 - 10:18am
tags:
Lipitor, Plavix, generics, CVS
Ranbaxy Drops on Report U.S. FDA Sent Letter on Manufacturing
Bloomberg
Friday, February 5, 2010 - 10:15am
tags:
FDA, Ranbaxy
Allergan’s Looking Real Pretty Right Now
CNBC
Friday, February 5, 2010 - 10:13am
tags:
Allergan
Abbott And Novartis Looking Good
Forbes
Friday, February 5, 2010 - 10:12am
tags:
Abbott Laboratories, Novartis
Stalled Health Care Bill Leaves Drug Makers in Regulatory Limbo
NY Times, NY
Friday, February 5, 2010 - 10:10am
tags:
healthcare bill, healthcare reform
Earnings Growth Proves Drugmaker Made Right Moves
Yahoo/AP
Friday, February 5, 2010 - 9:53am
tags:
earnings, Merck KGaA, Mylan, Teva Pharmaceuticals, Sandoz, Novartis
BioMarin to Acquire LEAD Therapeutics
Yahoo
Thursday, February 4, 2010 - 4:05pm
tags:
Biomarin, LEAD Therapeutics, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.